POSTNATAL HYDROCORTISONE TREATMENT FOR CHRONIC LUNG DISEASE IN THE PRETERM NEWBORN AND LONG TERM NEURODEVELOPMENTAL FOLLO UP
Guardat en:
RADEMAKER, K.J., ET AL., POSTNATAL HYDROCORTISONE TREATMENT FOR CHRONIC LUNG DISEASE IN THE PRETERM NEWBORN AND LONG TERM NEURODEVELOPMENTAL FOLLO UP. ARCHIVES OF DISEASE IN CHILDHOOD, Vol. 93, no. 1 (2008), p. F58-F63.
Ref.
148698
Localització:
SIIS R.186 Archivo
Palabras clave:
Discapacidad, Efectos, Enfermedades crónicas, Enfermedades respiratorias, Fármacos, Infancia, Recién nacido, Tratamiento médico
Discapacidad, Efectos, Enfermedades crónicas, Enfermedades respiratorias, Fármacos, Infancia, Recién nacido, Tratamiento médico
Ítems similars: POSTNATAL HYDROCORTISONE TREATMENT FOR CHRONIC LUNG DISEASE IN THE PRETERM NEWBORN AND LONG TERM NEURODEVELOPMENTAL FOLLO UP
- OUTCOME AT 4 TO 5 YEARS OF AGE IN CHILDREN RECOVERED FROM NEONATAL CHRONIC LUNG DISEASE
- THE CHANGING PATTERN OF CHRONIC LUNG DISEASE OF PREMATURITY
- Age at diagnosis and disease progression of cystic fibrosis in an area without newborn screening
- OXYGEN THERAPY FOR INFANTS WITH CHRONIC LUNG DISEASE
- VERY-LOW-BIRTHWEIGHT INFANTS AT SEVEN YEARS: AN ASSESSMENT OF THE HEALTH AND NEURODEVELOPMENTAL RISK CONVEYED BY CHRONIC LUNG DISEASE
- COMPOSITION OF POSTNATAL WEIGHT LOSS AND SUBSEQUENT WEIGHT GAIN IN SMALL FOR DATES NEWBORN INFANTS